XML 94 R84.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Incentive Plan - Summary of Company's Outstanding Restricted Common Stock (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   88,422
Expected future remaining compensation expense | $ $ 1,295 $ 1,295
Expected future compensation expense, restricted shares remaining vesting period   2 years 4 months 13 days
Restricted Shares Awarded on March 14, 2019 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   1,924
Date of Award   Mar. 14, 2019
Expected future remaining compensation expense | $ 9 $ 9
Expected future compensation expense, restricted shares remaining vesting period   3 months
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,265
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 51 $ 51
Expected future compensation expense, restricted shares remaining vesting period   1 year 3 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   7,776
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 103 $ 103
Expected future compensation expense, restricted shares remaining vesting period   2 years 3 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   6,793
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 33 $ 33
Expected future compensation expense, restricted shares remaining vesting period   3 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   9,554
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 177 $ 177
Expected future compensation expense, restricted shares remaining vesting period   3 years 3 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   11,261
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 160 $ 160
Expected future compensation expense, restricted shares remaining vesting period   1 year 3 months
Restricted Shares Awarded on March 14, 2023 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   17,103
Date of Award   Mar. 14, 2023
Expected future remaining compensation expense | $ 296 $ 296
Expected future compensation expense, restricted shares remaining vesting period   4 years 3 months
Restricted Shares Awarded on March 14, 2023 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   29,746
Date of Award   Mar. 14, 2023
Expected future remaining compensation expense | $ $ 466 $ 466
Expected future compensation expense, restricted shares remaining vesting period   2 years 3 months
Restricted Stock [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Nonvested at beginning of period 88,422 70,096
Number of Restricted Shares, Granted 0 47,536
Number of Restricted Shares, Vested 0 (27,470)
Number of Restricted Shares, Forfeited   (1,740)
Number of Restricted Shares, Nonvested at end of period 88,422 88,422
Weighted Average Grant Date Fair Value, Nonvested at beginning of period | $ / shares $ 21.98 $ 21.88
Weighted Average Grant Date Fair Value, Granted | $ / shares 0 21.85
Weighted Average Grant Date Fair Value, Vested | $ / shares 0 21.52
Weighted Average Grant Date Fair Value, Forfeited | $ / shares   21.74
Weighted Average Grant Date Fair Value, Nonvested at end of period | $ / shares $ 21.98 $ 21.98